Last updated: April 2, 2024
Sponsor: University Hospital, Bordeaux
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urologic Cancer
Urothelial Tract Cancer
Urothelial Cancer
Treatment
Uroconnect Follow Up Group
Clinical Study ID
NCT06047600
CHUBX2022/77
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Planned surgical management by total or partial nephrectomy for kidney tumor,
- Affiliation or beneficiary of the French social security
- Expressed consent for integration of the UroCCR cohort,
- Expressed consent to participate in the DiPRU study.
Exclusion
Exclusion Criteria:
- Difficulties understanding and expressing oneself in French
- Participant under guardianship or curatorship
- Pregnancy at the time of surgery
- No internet access
Study Design
Total Participants: 858
Treatment Group(s): 1
Primary Treatment: Uroconnect Follow Up Group
Phase:
Study Start date:
October 23, 2023
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
CHU d'Angers
Angers,
FranceActive - Recruiting
CHU de Bordeaux
Bordeaux,
FranceActive - Recruiting
Centre Catalan d'Urologie
Cabestany,
FranceActive - Recruiting
CHU de Caen
Caen,
FranceActive - Recruiting
Hôpital Henri Mondor
Créteil,
FranceActive - Recruiting
APHM
Marseille,
FranceActive - Recruiting
CH de Mont de Marsan
Mont-de-Marsan,
FranceActive - Recruiting
CHU de Nîmes
Nîmes,
FranceActive - Recruiting
CHU de Rennes
Rennes,
FranceActive - Recruiting
CHU de Strasbourg
Strasbourg,
FranceActive - Recruiting
CHu de Toulouse
Toulouse,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.